Development of Interleukin-1 Receptor Antagonist Mutants with Enhanced Antagonistic ActivityIn Vitroand Improved Therapeutic Efficacy in Collagen-Induced Arthritis-Reference-Cited by-同舟云学术

Development of Interleukin-1 Receptor Antagonist Mutants with Enhanced Antagonistic ActivityIn Vitroand Improved Therapeutic Efficacy in Collagen-Induced Arthritis

Published:2008-01 Issue:2 Volume:5 Page:189-199
ISSN:1547-691X
Container-title:Journal of Immunotoxicology
language:en
Short-container-title:Journal of Immunotoxicology

Author:

Dahlén Eva,Barchan Karin,Herrlander Daniel,Höjman Patrik,Karlsson Marie,Ljung Lill,Andersson Mats,Bäckman Eva,Hager Ann-Christin Malmborg,Walse Björn,Joosten Leo,van den Berg Wim

Publisher

Informa UK Limited

Subject

Toxicology,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.1080/15476910802131477

Reference36 articles.

1. Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein

2. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Expression of MicroRNAs in Rheumatoid Arthritis;Journal of Cellular Biochemistry;2017-07-11

2. Glatiramer acetate (GA), the immunomodulatory drug, inhibits inflammatory mediators and collagen degradation in osteoarthritis (OA) cartilage;Osteoarthritis and Cartilage;2011-09

3. Cytokine–receptor interactions as drug targets;Current Opinion in Chemical Biology;2010-08

4. Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies;Protein Engineering, Design and Selection;2009-12-03